EXC Stock DD Exelon Corp. Sunday, April 27, 2014 8:45:49 PM

New Post Public Reply Private Reply Replies (0) Message Board

Apr 27, 2014 at 9:45 PM

EXC Exelon Corp. $EXC Company Overview

Stock Message Board http://investorshangout.com/search?q=EXC&...mp;yt1=Go!

Last Updated: Sunday, April 27, 2014 8:45:49 PM

Exelon Corp. EXC Current Price and Quotes
Last Price 36.26
Previous Close 36.01 Open 36.01
Daily Range 35.90 - 36.30 52wk Range 26.45 - 37.80
Volume 5,107,106 Dividend 1.24
Average Vol (3m) 7,147,508 Yield 3.4197
Exelon Corp. EXC

Exelon Corp. EXC
Exelon Corp. EXC

Exelon Corp. EXC

Exelon Corp. EXC Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 24,888,000 23,489,000 19,063,000 18,644,000
Cost of Revenue 17,994,000 18,118,000 12,451,000 11,035,000
Gross Profit 6,894,000 5,371,000 6,612,000 7,609,000
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 1,095,000 1,019,000 785,000 808,000
Non-Recurring Items - - - -
Other 2,153,000 1,881,000 1,347,000 2,075,000
Operating Income 3,656,000 2,380,000 4,479,000 4,726,000
Income From Continuing Operations

Add'l Income/Expense Items 473,000 346,000 203,000 312,000
Earnings Before Interest and Tax 4,129,000 2,726,000 4,682,000 5,038,000
Interest Expense 1,356,000 928,000 726,000 817,000
Earnings Before Tax 2,773,000 1,798,000 3,956,000 4,221,000
Income Tax 1,044,000 627,000 1,457,000 1,658,000
Minority Interest 10,000 11,000 4,000 -
Equity Earnings Unconsolidated Subsidiary 10,000 (91,000) (1,000) -
Net Income Cont. Operations 1,729,000 1,069,000 2,494,000 2,563,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,729,000 1,069,000 2,494,000 2,563,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,719,000 1,160,000 2,495,000 2,563,000

Exelon Corp. EXC Recent News

Apr 25, 2014 Plant Green to Save Green with PECO's New Energy-Saving Trees Program
Apr 24, 2014 Exelon Hosts Spring Innovation Expo Focused on Data Driven Decisions
Apr 24, 2014 ComEd Smart Meters - Produced by GE - Certified by UL
Apr 23, 2014 Exelon Urges Lawmakers to Take Hard Look at Energy Policies to Preserve Benefits of Nation's Nuclear Plants
Apr 23, 2014 Exelon Completes Ambitious Goal for Eliminating Carbon Emissions Seven Years Ahead of Schedule
Apr 21, 2014 PECO Crown Lights Going Green for Earth Day
Apr 16, 2014 ComEd Files Rate Request to Support Smart Grid in Illinois
Apr 15, 2014 Management Addresses the Conference, Upcoming Earnings Releases, and Conference Call Schedules - Analyst Notes on Dominion, Exelon, Duke Energy, Southern Company, and Edison
Apr 14, 2014 ColorWheels, with Events Sponsored by PECO, Rolls out for 2014
Apr 10, 2014 ComEd Partners with Nest to Offer Customers Energy Savings and Rebates

1
2
3
4
5
6
7
next >

EXC Exelon Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=EXC&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/EXC/quote
Stock Chart http://www.otcmarkets.com/stock/EXC/chart
Company Info http://www.otcmarkets.com/stock/EXC/company-info
Recent News http://www.otcmarkets.com/stock/EXC/news
Financials http://www.otcmarkets.com/stock/EXC/financials
Filings and Disclosure http://www.otcmarkets.com/stock/EXC/filings
Short Sales http://www.otcmarkets.com/stock/EXC/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/EXC/insider-transactions
Research Reports http://www.otcmarkets.com/stock/EXC/research
Summary http://finance.yahoo.com/q?s=EXC
Historical Prices http://finance.yahoo.com/q/hp?s=EXC+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=EXC
Basic Chart http://finance.yahoo.com/q/bc?s=EXC+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=EXC+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=EXC+Headlines
Press Releases http://finance.yahoo.com/q/p?s=EXC+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=EXC+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=EXC+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=EXC+Industry
Major Holders http://finance.yahoo.com/q/mh?s=EXC+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=EXC+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=EXC+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=EXC
Balance Sheet http://finance.yahoo.com/q/bs?s=EXC
Cash Flow http://finance.yahoo.com/q/cf?s=EXC+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/EXC
Market Watch http://www.marketwatch.com/investing/stock/EXC
Bloomberg http://www.bloomberg.com/quote/EXC:US
Morningstar http://quotes.morningstar.com/stock/s?t=EXC
Bussinessweek http://investing.businessweek.com/research/st...ticker=EXC
Barchart http://www.barchart.com/quotes/stocks/EXC
OTC Short Report http://otcshortreport.com/index.php?index=EXC
Investopedia http://www.investopedia.com/markets/stocks/EXC/?wa=0

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...